Engineering phage therapeutics with intrinsic biocontainment.
This work evaluates emerging biocontainment strategies for therapeutic phages and proposes a framework for assessing trade-offs between biocontainment stringency, evolutionary robustness against escape mutants, therapeutic efficacy, and translational feasibility.